Patient preferences explored in multiple myeloma treatment

2020-12-11T16:06:49+01:00Agosto 20th, 2019|Pubblicazioni|0 Commenti

(HealthDay)—An Eastern Cooperative Oncology Group (ECOG) performance status of ≥2 is linked to lower treatment satisfaction in patients with relapsed or refractory multiple myeloma (RRMM), [...]